{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:04:31Z","timestamp":1779710671249,"version":"3.53.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["110TMU-SHH-21"],"award-info":[{"award-number":["110TMU-SHH-21"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["111TMU-SHH-17"],"award-info":[{"award-number":["111TMU-SHH-17"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["1-111CMUBHR-10"],"award-info":[{"award-number":["1-111CMUBHR-10"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["1-110CMUBHR-12"],"award-info":[{"award-number":["1-110CMUBHR-12"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NHRI-109BCCO-MF-202005-06"],"award-info":[{"award-number":["NHRI-109BCCO-MF-202005-06"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114-2314-B038-074-MY3"],"award-info":[{"award-number":["NSTC114-2314-B038-074-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2314-B038-118-MY3"],"award-info":[{"award-number":["NSTC113-2314-B038-118-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114-2314-B038-078-MY3"],"award-info":[{"award-number":["NSTC114-2314-B038-078-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejps.2026.107497","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:43:59Z","timestamp":1772671439000},"page":"107497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the xylosyltransferase TMEM5 in glioblastoma to modulate CLOCK and CRY1 expression and restore temozolomide sensitivity via the circadian signaling axis"],"prefix":"10.1016","volume":"221","author":[{"given":"Yu-Kai","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijesh Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iat-Hang","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-0145","authenticated-orcid":false,"given":"Chien-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107497_bib0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10928-021-09751-2","article-title":"Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions","volume":"48","author":"Ayyar","year":"2021","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2026.107497_bib0002","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.aah4965","article-title":"Circadian time signatures of fitness and disease","volume":"354","author":"Bass","year":"2016","journal-title":"Sci. (N. Y. N.Y.)"},{"key":"10.1016\/j.ejps.2026.107497_bib0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-013-0345-4","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"13","author":"Cohen","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ejps.2026.107497_bib0004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/smrv.2001.0190","article-title":"Circadian rhythm sleep disorders (CRSD)","volume":"6","author":"Dagan","year":"2002","journal-title":"Sleep med. Rev."},{"key":"10.1016\/j.ejps.2026.107497_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2023.1157654","article-title":"TimeTeller for timing health: the potential of circadian medicine to improve performance, prevent disease and optimize treatment","volume":"5","author":"Dose","year":"2023","journal-title":"Front. Digit. Health"},{"key":"10.1016\/j.ejps.2026.107497_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41392-022-00899-y","article-title":"Molecular regulations of circadian rhythm and implications for physiology and diseases","volume":"7","author":"Fagiani","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2026.107497_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092044","article-title":"Multiregional sequencing of IDH-WT glioblastoma reveals high genetic heterogeneity and a dynamic evolutionary history","volume":"13","author":"Franceschi","year":"2021","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ejps.2026.107497_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-396971-2.00009-9","article-title":"The circadian clock in cancer development and therapy","volume":"119","author":"Fu","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ejps.2026.107497_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.11.012","article-title":"Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host","volume":"43","author":"Gonzalez-Aponte","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejps.2026.107497_bib0010","first-page":"3","article-title":"Glioblastoma Multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment","volume":"18","author":"Hanif","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ejps.2026.107497_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1244740","article-title":"The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer","volume":"13","author":"Herrera-Quiterio","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2026.107497_bib0012","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","article-title":"Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours","volume":"18","author":"Horbinski","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejps.2026.107497_bib0013","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s12276-024-01206-1","article-title":"Transmembrane proteins with unknown function (TMEMs) as ion channels: electrophysiological properties, structure, and pathophysiological roles","volume":"56","author":"Kang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejps.2026.107497_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.759153","article-title":"Impact of circadian rhythms on the development and clinical management of genitourinary cancers","volume":"12","author":"Kaur","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2026.107497_bib0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1101\/gad.261982.115","article-title":"Cancer stem cells in glioblastoma","volume":"29","author":"Lathia","year":"2015","journal-title":"Genes dev."},{"key":"10.1016\/j.ejps.2026.107497_bib0016","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s12276-021-00681-0","article-title":"Roles of circadian clocks in cancer pathogenesis and treatment","volume":"53","author":"Lee","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejps.2026.107497_bib0017","article-title":"Potential role of the circadian clock in the regulation of cancer stem cells and cancer therapy","volume":"23","author":"Lee","year":"2022","journal-title":"Int. j. mol. sci."},{"key":"10.1016\/j.ejps.2026.107497_bib0018","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.celrep.2018.01.077","article-title":"Cry2 Is critical for circadian regulation of myogenic differentiation by Bclaf1-mediated mRNA stabilization of Cyclin D1 and Tmem176b","volume":"22","author":"Lowe","year":"2018","journal-title":"Cell rep."},{"key":"10.1016\/j.ejps.2026.107497_bib0019","doi-asserted-by":"crossref","first-page":"24618","DOI":"10.1074\/jbc.M116.751917","article-title":"The muscular dystrophy gene TMEM5 encodes a ribitol \u03b21,4-xylosyltransferase required for the functional glycosylation of dystroglycan","volume":"291","author":"Manya","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2026.107497_bib0020","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41591-018-0271-8","article-title":"The emerging link between cancer, metabolism, and circadian rhythms","volume":"24","author":"Masri","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2026.107497_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1335730","article-title":"Perioperative dexamethasone in high-grade gliomas: the short-term benefits and long-term harms","volume":"13","author":"Mistry","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2026.107497_bib0022","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41698-025-01205-z","article-title":"Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK\u2013PD modelling to optimize temozolomide timing","volume":"10","author":"Nelson","year":"2025","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.ejps.2026.107497_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-invasive drug delivery across the blood-brain barrier: A prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2026.107497_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/science.1243417","article-title":"Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice","volume":"342","author":"Peek","year":"2013","journal-title":"Sci. (N. Y. N.Y.)"},{"key":"10.1016\/j.ejps.2026.107497_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104470","article-title":"Chronotherapy in Glioblastoma: state of the art and future perspectives","volume":"89","author":"Petkovi\u0107","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejps.2026.107497_bib0026","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes. Cancer"},{"key":"10.1016\/j.ejps.2026.107497_bib0027","doi-asserted-by":"crossref","first-page":"4","DOI":"10.37349\/en.2022.00002","article-title":"Impact of circadian clock dysfunction on human health","volume":"1","author":"Samanta","year":"2022","journal-title":"Explor. Neurosci."},{"key":"10.1016\/j.ejps.2026.107497_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071393","article-title":"Dexamethasone in patients with glioblastoma: A systematic review and meta-analysis","volume":"16","author":"Scheffler","year":"2024","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ejps.2026.107497_bib0029","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3389\/fphar.2018.01345","article-title":"TMEM Proteins in cancer: A review","volume":"9","author":"Schmit","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107497_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1022716","article-title":"Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization","volume":"12","author":"Silver","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2026.107497_bib0031","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jcma.2016.03.010","article-title":"Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells","volume":"79","author":"Song","year":"2016","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.ejps.2026.107497_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7030069","article-title":"Temozolomide and other alkylating agents in glioblastoma therapy","volume":"7","author":"Strobel","year":"2019","journal-title":"Biomedicines."},{"key":"10.1016\/j.ejps.2026.107497_bib0033","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","article-title":"Interplay between circadian clock and cancer: new frontiers for cancer treatment","volume":"5","author":"Sulli","year":"2019","journal-title":"Trends. Cancer"},{"key":"10.1016\/j.ejps.2026.107497_bib0034","article-title":"Genetic abnormalities, clonal evolution, and cancer stem cells of brain tumors","volume":"6","author":"Testa","year":"2018","journal-title":"Med. Sci. (Basel Switz.)"},{"key":"10.1016\/j.ejps.2026.107497_bib0035","first-page":"1","article-title":"Advances in the management of glioblastoma: the role of temozolomide and MGMT testing","volume":"5","author":"Thomas","year":"2013","journal-title":"Clin. Pharmacol. : Adv. Appl."},{"key":"10.1016\/j.ejps.2026.107497_bib0036","first-page":"e1947","article-title":"Immunotherapy: advancing glioblastoma treatment-A narrative review of scientific studies","volume":"7","author":"Tiwari","year":"2023","journal-title":"Cancer Rep. (Hob. N.J.)"},{"key":"10.1016\/j.ejps.2026.107497_bib0037","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.7150\/thno.69682","article-title":"Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy","volume":"12","author":"Upton","year":"2022","journal-title":"Theranostics."},{"key":"10.1016\/j.ejps.2026.107497_bib0038","doi-asserted-by":"crossref","DOI":"10.37349\/eemd.2025.101437","article-title":"Glucocorticoid signalling coordinating circadian rhythms between the glymphatic system and sleep contributes to brain health","volume":"2","author":"van der Zwet","year":"2025","journal-title":"Explor. Endocr. Metab. Dis."},{"key":"10.1016\/j.ejps.2026.107497_bib0039","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/mds.26509","article-title":"Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?","volume":"31","author":"Videnovic","year":"2016","journal-title":"Mov. Disord. : Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.ejps.2026.107497_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102416","article-title":"Alterations in molecular profiles affecting glioblastoma resistance to radiochemotherapy: where does the good go?","volume":"14","author":"Vilar","year":"2022","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ejps.2026.107497_bib0041","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3727\/096504018X15478559215014","article-title":"Inhibition of proliferation by knockdown of transmembrane (TMEM) 168 in glioblastoma cells via suppression of wnt\/\u03b2-catenin pathway","volume":"27","author":"Xu","year":"2019","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ejps.2026.107497_bib0042","first-page":"5091","article-title":"Research progress on circadian clock genes in common abdominal malignant tumors","volume":"14","author":"Yang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejps.2026.107497_bib0043","article-title":"Emerging insight into the role of circadian clock gene BMAL1 in cellular senescence","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ejps.2026.107497_bib0044","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41419-021-04211-8","article-title":"Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated wnt signaling in breast cancer","volume":"12","author":"Zhu","year":"2021","journal-title":"Cell Death. Dis."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:50:27Z","timestamp":1779709827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0928098726000710"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107497","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the xylosyltransferase TMEM5 in glioblastoma to modulate CLOCK and CRY1 expression and restore temozolomide sensitivity via the circadian signaling axis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107497"}}